ID

27182

Descrizione

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01038804

collegamento

https://clinicaltrials.gov/show/NCT01038804

Keywords

versioni (1)
  1. 02/11/17 02/11/17 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

2 novembre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT01038804

Inglese

Eligibility Breast Cancer NCT01038804

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically- or cytologically-proven adenocarcinoma of the breast that is her2 negative. subjects with hormone receptor positive or negative status are eligible. additionally, subjects with triple negative status (meaning estrogen receptor negative, progesterone receptor negative and her2 negative) are eligible
Descrizione

Breast adenocarcinoma HER2 negative | Hormone Receptor Status Positive | Hormone Receptor Status Negative | Triple-Negative Breast Cancer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C4087376
UMLS CUI [2,1]
C0019929
UMLS CUI [2,2]
C0449438
UMLS CUI [2,3]
C1514241
UMLS CUI [3,1]
C0019929
UMLS CUI [3,2]
C0449438
UMLS CUI [3,3]
C1513916
UMLS CUI [4]
C2348819
no prior chemotherapy regimen for metastatic breast cancer
Descrizione

Prior Chemotherapy Absent Secondary malignant neoplasm of female breast

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0346993
eastern cooperative oncology group (ecog) performance status ≤ 1 at the baseline visit
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
the subject's life expectancy is estimated to be > 12 weeks at the baseline visit
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
the subject must be non-pregnant and non-lactating. all sexually active subjects of childbearing potential must agree to use an adequate method of contraception throughout the study period
Descrizione

Pregnancy Absent | Breast Feeding Absent | Childbearing Potential Sexually active Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0241028
UMLS CUI [3,3]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
hypersensitivity to docetaxel or polysorbate 80
Descrizione

Hypersensitivity docetaxel | Hypersensitivity Polysorbate 80

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0032601
neuropathy ≥ grade 2 at the baseline visit
Descrizione

Neuropathy CTCAE Grades

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
known brain or leptomeningeal metastasis as assessed through medical history review and physical examination
Descrizione

Metastatic malignant neoplasm to brain Medical History | Metastatic Malignant Neoplasm to the Leptomeninges Medical History | Metastatic malignant neoplasm to brain Physical Examination | Metastatic Malignant Neoplasm to the Leptomeninges Physical Examination

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C1704231
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0220650
UMLS CUI [3,2]
C0031809
UMLS CUI [4,1]
C1704231
UMLS CUI [4,2]
C0031809
the subject has known human immunodeficiency virus (hiv), hepatitis b surface antigen or hepatitis c antibody
Descrizione

HIV Antibodies | Hepatitis B Virus Surface Antibody | Hepatitis C Antibodies

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019683
UMLS CUI [2]
C0369334
UMLS CUI [3]
C0166049
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT01038804

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma HER2 negative | Hormone Receptor Status Positive | Hormone Receptor Status Negative | Triple-Negative Breast Cancer
Item
histologically- or cytologically-proven adenocarcinoma of the breast that is her2 negative. subjects with hormone receptor positive or negative status are eligible. additionally, subjects with triple negative status (meaning estrogen receptor negative, progesterone receptor negative and her2 negative) are eligible
boolean
C0858252 (UMLS CUI [1,1])
C4087376 (UMLS CUI [1,2])
C0019929 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])
C1514241 (UMLS CUI [2,3])
C0019929 (UMLS CUI [3,1])
C0449438 (UMLS CUI [3,2])
C1513916 (UMLS CUI [3,3])
C2348819 (UMLS CUI [4])
Prior Chemotherapy Absent Secondary malignant neoplasm of female breast
Item
no prior chemotherapy regimen for metastatic breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0346993 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status ≤ 1 at the baseline visit
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
the subject's life expectancy is estimated to be > 12 weeks at the baseline visit
boolean
C0023671 (UMLS CUI [1])
Pregnancy Absent | Breast Feeding Absent | Childbearing Potential Sexually active Contraceptive methods
Item
the subject must be non-pregnant and non-lactating. all sexually active subjects of childbearing potential must agree to use an adequate method of contraception throughout the study period
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity docetaxel | Hypersensitivity Polysorbate 80
Item
hypersensitivity to docetaxel or polysorbate 80
boolean
C0020517 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0032601 (UMLS CUI [2,2])
Neuropathy CTCAE Grades
Item
neuropathy ≥ grade 2 at the baseline visit
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Medical History | Metastatic Malignant Neoplasm to the Leptomeninges Medical History | Metastatic malignant neoplasm to brain Physical Examination | Metastatic Malignant Neoplasm to the Leptomeninges Physical Examination
Item
known brain or leptomeningeal metastasis as assessed through medical history review and physical examination
boolean
C0220650 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1704231 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0220650 (UMLS CUI [3,1])
C0031809 (UMLS CUI [3,2])
C1704231 (UMLS CUI [4,1])
C0031809 (UMLS CUI [4,2])
HIV Antibodies | Hepatitis B Virus Surface Antibody | Hepatitis C Antibodies
Item
the subject has known human immunodeficiency virus (hiv), hepatitis b surface antigen or hepatitis c antibody
boolean
C0019683 (UMLS CUI [1])
C0369334 (UMLS CUI [2])
C0166049 (UMLS CUI [3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial